Extramedullary hematopoiesis in the kidneys in infant siblings with myelofibrosis

S K Fernbach1, K A Feinstein

  • 1Children's Memorial Hospital, Chicago, Illinois.

Pediatric Radiology
|January 1, 1992
PubMed

Insights

Extramedullary hematopoiesis (EMH), the formation of blood products outside the bone marrow, is rare in children. This study describes two young girls with severe anemia who developed EMH, including rare kidney involvement.

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Pathophysiology

Background:

  • Extramedullary hematopoiesis (EMH) typically occurs in adults with severe anemia due to the limited capacity of pediatric bone marrow.
  • Children usually compensate for anemia by utilizing their extensive red marrow reserves.

Observation:

  • Two young girls with severe anemia were observed.
  • These patients exhibited extramedullary hematopoiesis (EMH) despite their young age.
  • One patient presented with documented and uncommon renal involvement.

Findings:

  • The observed cases challenge the typical age distribution of EMH.
  • The findings highlight the potential for EMH in pediatric patients with severe anemia who cannot adequately produce blood products in the marrow.
  • Rare renal involvement in pediatric EMH was documented.

Implications:

  • This study expands the understanding of EMH presentation in pediatric populations.
  • It suggests that EMH should be considered in the differential diagnosis of severe anemia in children, even with unusual organ involvement.
  • Further research into the mechanisms and management of pediatric EMH is warranted.

Related Concept Videos

Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...